Pharmacy benefits managers, or PBMs, are meant to act as a middleman between drug manufacturers and insurance companies, with ...

While it may seem strange that politics could impact the price of popular weight loss drugs, it is a definite possibility.

The bill's supporters framed it as part of the solution to addressing both high drug prices and slowing the pace of pharmacy ...

More than 100 pharmacies across Kansas closed Wednesday as workers meet with state lawmakers in Topeka. They hope to bring to light their concerns regarding pharmacy benefit managers, better known as ...

Congress nearly passed legislation to restrict pharmacy benefit manager business practices at the end of 2024.

In particular, the charges have targeted two lawmakers typically seen as pharma foes: Sens. Bernie Sanders (I-Vt.) and ...

Wednesday, 92 independent, mom-pop pharmacies across the state will close their doors for a day of advocacy in Topeka. It’s a ...

The FTC called out the nation’s leading pharmacy benefit managers for inflating pharmacy costs, affecting both employers and ...

In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus. Lantus cost $292 for a 30-day supply. Drugmaker Viatris launched two versions ...

Pharmacists in the Four-States say their livelihoods are at risk as major companies gain more control of the drug market. They're warning that Pharmacy Benefit Mangers, better known as PBMs, have an ...

Cigna executives kicked off Thursday’s earnings call by responding to pharmacy benefit manager critics with a number of reforms.

Cigna has deleveraged substantially after acquiring Express Scripts in late 2018 when Cigna's debt rose to over $42 billion, or debt/capital of 51%. Management has made good progress on its ...